The FDA has granted Fast Track designation to KT-621, a first-in-class oral STAT6 degrader for moderate to severe ...

GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick ...

This summer’s family barbecue was supposed to be a celebration of sorts—coming together for the first time since the pandemic pulled the plug on group activities. But your joy was cut short by an ...

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...

Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...

Asthma patients can help their own health, and that of others, by taking part in clinical trials. There's no charge for ...

A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma attacks. Scientists at La Jolla Institute for Immunology (LJI) are ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma attacks. Scientists at La Jolla Institute for Immunology (LJI) are ...

The price of asthma medication has soared in the U.S. over the past decade and a half. I’m a health law professor at Villanova University, where I study whether patients can get the medicines they ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...

Quick-relief meds, also called rescue or short-acting drugs, are just what they sound like an 11th-hour Hail Mary when an asthma attack kicks in. “Whereas long-term and control medications treat ...